FDA Drug recall D-0253-2015
LOSARTAN POTASSIUM TABLETS USP, 25 mg, 1000 Tablet Bottles, Rx Only
- FDA Drug
- Class II
- terminated
- Published 2014-11-26
On 2014-11-26 the FDA classified a Class II recall of LOSARTAN POTASSIUM TABLETS USP, 25 mg, 1000 Tablet Bottles, Rx Only by Micro Labs Usa S, citing failed Content Uniformity Specifications; Dry mix failed blend uniformity.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0253-2015 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-09-22 |
| Published | 2014-11-26 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Micro Labs Usa S |
| Distribution | NY |
Product
LOSARTAN POTASSIUM TABLETS USP, 25 mg, 1000 Tablet Bottles, Rx Only. Manufactured by: Micro Labs Limited, Goa-403 722, INDIA. Manufactured for: Micro Labs USA, Inc., Princeton, NJ 08540. NDC 42571-110-10
Reason
Failed Content Uniformity Specifications; Dry mix failed blend uniformity.
Identifiers
| code_info | Lot #LJAG003, Expiry: 05/2015 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0253-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.